FROM FOX NEWS: New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss.
Two studies, published in JAMA, analyzed how semaglutide and tirzepatide — which include popular drugs like Ozempic, Wegovy, Mounjaro and Zepbound — impacted eye health in Americans with type 2 diabetes over a two-year period.
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN) – a rare eye condition that can lead to sudden vision loss due to lack of blood flow – in association with semaglutide and tirzepatide.
Researchers also found an increased risk of developing “other optic nerve disorders.”
“These findings suggest that all patients with type 2 diabetes treated with GLP-1 RAs, regardless of preexisting diabetic retinopathy, should be regularly screened and monitored for potential complications,” the study authors concluded.
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition that can lead to sudden vision loss due to lack of blood flow. https://t.co/KDT6orOE7A
— FOX 5 DC (@fox5dc) August 13, 2025
READ MORE AT FOX NEWS
